Previous Article | Next Article ![]()
Eukaryotic Cell, September 2005, p. 1595-1598, Vol. 4, No. 9
1535-9778/05/$08.00+0 doi:10.1128/EC.4.9.1595-1598.2005
Copyright © 2005, American Society for Microbiology. All Rights Reserved.
The University of Liverpool, School of Biological Sciences, Bioscience Building, Crown Street, Liverpool L69 7ZB, United Kingdom
Received 4 July 2005/ Accepted 14 July 2005
|
|
|---|
|
|
|---|
Sirolimus causes growth inhibition in yeasts and filamentous fungi, including Aspergillus fumigatus (26). In A. nidulans, sirolimus has fungistatic activity, causing severely reduced growth and conidiation (Fig. 1). Mutations in areA do not alter sirolimus sensitivity, whereas S. cerevisiae gln3 gat1 double mutants show partial resistance (3). Unlike for S. cerevisiae, where sirolimus treatment in a nitrogen-rich medium results in rapid expression of genes subject to nitrogen metabolite repression, such as the general amino acid permease gene GAP1 and the glutamine synthase gene GLN1 (3, 6), we did not detect induction of AN5678.2 (homologue of S. cerevisiae GAP1), glnA (glutamine synthase), areA, or mepA (ammonium permease) in Northern blot analysis over a 30-min time course (data not shown). This indicates that, unlike in S. cerevisiae, sirolimus does not override nitrogen metabolite signaling in A. nidulans.
![]() View larger version (83K): [in a new window] |
FIG. 1. Growth tests for the wild type and sirolimus-resistant mutants. The effects of sirolimus on the growth of the wild-type (+//+) and torA3 heterozygote (torA3//+) diploids, as well as the wild-type (+), fprA1, jipA10, nmrA , and jipA10 nmrA haploid strains, are shown. Nitrogen source utilization was tested by growing the strains on supplemented minimal media containing NH4+, threonine (thr), uric acid (UA), urea, NO3, or 2-pyrrolidone (pyrr) at 10 mM. Sirolimus (rap) was added at a final concentration of 200 ng/ml to supplemented minimal medium containing 10 mM NH4+. Nitrogen metabolite derepression was assessed using chlorate (ClO3) at 500 mM or DL-aspartic acid ß-hydroxamate at either 1 mM (DLaa1) or 10 mM (DLaa10) or on minimal medium supplemented with 10 mM NH4+.
|
To identify the mutations within the sirolimus-resistant strains, we used a combination of bioinformatics, PCR, and sequencing. Assembly and annotation of the public A. nidulans genome sequence proceeded during the course of our work. BLAST searches using protein sequences from other organisms submitted to A. nidulans databases aided identification.
A single Tor kinase gene homologue on LG I which we named torA (accession no. AJ717403) was identified in A. nidulans. Based on reverse transcription (RT)-PCR, the putative protein is 2,385 amino acids long and contains all the domains associated with Tor function (Fig. 2A). Full disruption of Tor activity is likely to be lethal, as has been shown in other fungi, including S. cerevisiae (20) and Fusarium fujikuroi (Sabine Teichert and Bettina Tudzynski, personal communication). PCR amplification and sequencing of the sirolimus-resistant diploid torA3 strain revealed a single point mutation at position 5751 that would result in Pro replacing Ser-1871 within the highly conserved sirolimus-binding domain (8). The dominant nature of the allele indicates that the mutant protein must retain some aspects of its function in the presence of sirolimus. Its apparent lethality in the haploid suggests either multimerization, where the heterodimer retains partial function in the presence of sirolimus, or that the wild-type Tor kinase retains essential sirolimus-tolerant functions affected by this mutation. In S. cerevisiae and mammalian systems, there is evidence for sirolimus-sensitive and -insensitive functions, but Tor multimerization has not been observed (15, 20, 21, 25, 29).
![]() View larger version (11K): [in a new window] |
FIG. 2. Domain map of the predicted TorA and JipA proteins. (A) TorA contains three HEAT repeats (177 to 217, 701 to 732, and 985 to 1025), a FAT domain (1241 to 1818), a sirolimus-binding domain (1819 to 1931), a phosphatidylinositol 3-kinase domain (1932 to 2272), and a FATC domain (2353 to 2385). The position of the Ser-to-Pro substitution of TorA3, which lies within the sirolimus-binding domain, is indicated ( ). (B) JipA (accession no. AJ717401) has a conserved central region (shaded region), conforming to the TIP41 domain of S. cerevisiae. Frameshift mutations in both jipA5 and jipA10 introduce premature stop codons, resulting in 92- and 49-amino-acid peptides, respectively. The mutant sequence is indicated (cross-hatched box). In the jipA5 strain, 24 residues of the TIP41 domain are present, whereas in the jipA10 strain the truncation is introduced before the domain.
|
C transition at position 485 in fprA7 altered one of three invariant residues (Phe-100
Ser) required for interaction between FKBP12-sirolimus and Tor kinase (22, 28).
![]() View larger version (50K): [in a new window] |
FIG. 3. The A. nidulans FKBP12 gene homologue fprA shares high levels of homology with homologues from Cryptococcus neoformans, S. cerevisiae, Homo sapiens, Mus musculus, and Drosophila melanogaster. Amino acid residues marked with asterisks represent the hydrophobic sirolimus- and FK506-binding pocket. The three amino acid residues marked with arrows represent the surface residues known to interact with the TOR proteins.
|
Growth tests were used to assess the effects of mutations in torA, fprA, and jipA on nitrogen metabolism (Fig. 1). The heterozygous diploid torA3/torA+ showed increased sensitivity to 10 mM DL-aspartic acid ß-hydroxamate in the presence of NH4+, indicating partial derepression of the asparaginase gene ahrA (11, 27). Both fprA and jipA showed weak pleiotropic effects on several nitrogen sources and had severely reduced growth on 2-pyrrolidone. The jipA strains showed marginally reduced growth irrespective of the nitrogen sources tested. The fprA1 and torA3 diploid strain showed enhanced growth on threonine. Interestingly, in S. cerevisiae FKBP12 has a role in aspartokinase feedback regulation of the threonine biosynthetic pathway (2).
A. nidulans does not have an orthologue of yeast URE2 (12). However, a structurally unrelated protein, NmrA, is known to interact with and inhibit AreA (1, 24) and therefore has similar function to Ure2p, which represses Gln3p. In S. cerevisiae, activity of the phosphatase Sit4p, required to release Gln3p from Ure2p, is inhibited by an interaction with Tap42p as part of the TOR network (3). Within the A. nidulans genome, we identified tapA (accession no. AJ717402) and sitA (accession no. AJ717404), homologues of TAP42 and SIT4, respectively, and confirmed their expression and intron structure using RT-PCR. As this arm of the TOR signaling network is conserved in A. nidulans, it was important to determine whether JipA effected nitrogen signaling through NmrA. We therefore constructed jipA10 nmrA
double mutants. These were sirolimus resistant, had reduced growth on nitrogen sources equivalent to jipA10 single mutants, were hypersensitive to DL-aspartic acid ß-hydroxamate, and were more sensitive to chlorate than either parental strain (Fig. 1). Results of plate tests for nitrite reductase activity were intermediate to those obtained with single mutants (data not shown). Deletion of nmrA results in asparaginase and nitrate reductase derepression (1), but poor growth observed on 2-pyrrolidone suggested that NmrA has a positive effect on the expression of some genes (Fig. 1). One interpretation is that NmrA may remain associated with AreA when it is active. The lack of a clear epistatic relationship suggests that JipA does not act through NmrA. Double mutants containing jipA10 and areA alleles lacking specific domains (N terminus, areA
2-389 [5]; C terminus, areA
743-864 [24]; and C-terminal GATA domain and consensus nuclear export signal, areA120 [7, 24]) also failed to give clear epistatic relationships (data not shown), indicating that TOR signaling is not effected specifically through any one of these regions.
Both jipA and fprA strains showed their most severe nitrogen utilization phenotypes on 2-pyrrolidone. Northern analysis was used to measure expression levels of the utilization genes lamA and lamB (18). Expression of both genes was significantly lower in jipA10 than the wild type over a 2-h time course after transfer from NH4+ to 2-pyrrolidone (Fig. 4). However, only lamA expression was significantly reduced in jipA10 and frpA1 strains when induced by ß-alanine, which is a good nitrogen source for both strains. This is consistent with the defects in 2-pyrrolidone utilization being due, in part, to reduced transcription of lamA.
![]() View larger version (45K): [in a new window] |
FIG. 4. Expression of lamA and lamB in wild-type (WT), jipA10, and fprA1 strains. (A) Northern analysis of lamA and lamB transcription in wild-type and jipA10 strains over a 2-h time course after transfer from NH4+ to 2-pyrrolidone as the sole nitrogen source. The level of the 18S rRNA transcript is shown as a control. Quantification of triplicate blots revealed a significantly reduced expression for both genes in the mutant strain. (B) lamA and lamB expression was also examined for wild-type, jipA10, and fprA1 strains after growth on ß-alanine as the sole nitrogen source for 4 h. Expression was induced >100-fold by ß-alanine compared with L-alanine, which was used as a noninducing control (data not shown). Graphs illustrate the expression levels of lamA and lamB relative to 18S rRNA as an average (± standard error) from three separate experiments quantified using a phosphorimager. lamA expression is significantly lower in the two mutant strains than in the wild type.
|
Nucleotide sequence accession numbers. Sequences from this study were submitted to GenBank and assigned accession no. AJ717400, AJ717401, AJ717402, AJ717403, and AJ717404.
We are grateful to Mike Hynes for providing us with an nmrA
strain.
|
|
|---|
This article has been cited by other articles:
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»